跳至主要内容
临床试验/ACTRN12620000359932
ACTRN12620000359932尚未招募未知

Probiotics in the prevention of Gestational Diabetes Mellitus in women at increased risk: a prospective randomised controlled trial.

Dr Anushika Samarage0 个研究点目标入组 340 人开始时间: 2020年3月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
Female

入选标准

  • All pregnant women >10 weeks gestation, in a singleton pregnancy at increased risk of gestational diabetes as per the Australasian Diabetes in Pregnancy Society (ADIPS) criteria will be eligible for the study:
  • Previous GDM
  • Maternal age 18 years to 40 years
  • Family history of diabetes (1st degree relative with diabetes or a sister with GDM)
  • BMI over 35kg/m2
  • Previous macrosomia (baby birth weight over 4500g or over 90th centile)
  • Polycystic ovarian syndrome

排除标准

  • Not being able to read and understand English – unable to provide informed consent.
  • Age <18 years
  • Pregnancy >16 weeks gestation at recruitment
  • Known pre-existing diabetes, impaired fasting glucose or impaired glucose tolerance
  • GDM prior to recruitment as diagnosed by early pregnancy glucose testing – Early
  • pregnancy glucose testing routinely done for women at increased risk of GDM
  • Medications likely to influence glucose metabolism – metformin, glucocorticoids,
  • immunosuppressants
  • Medical conditions with altered glucose metabolism – Cushing/s syndrome, hepatic
  • Known major fetal anomaly on ultrasound
  • Known current ingestion of probiotics via capsules or sachets
  • Antibiotic use during the study period

研究者

发起方
Dr Anushika Samarage

相似试验